76 related articles for article (PubMed ID: 3012782)
1. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!
Lu W
J Hepatol; 2024 Jun; 80(6):e267-e268. PubMed ID: 37797791
[No Abstract] [Full Text] [Related]
2. Much More Is Needed From Hepatitis B Core-Related Antigen to Predict Risk of Liver Cancer.
Singh SP; Jindal A; Sharma MK; Sarin SK
Am J Gastroenterol; 2023 Jan; 118(1):178. PubMed ID: 35971236
[No Abstract] [Full Text] [Related]
3. Development and Validation of a Novel Risk Prediction Model Using Recursive Feature Elimination Algorithm for Acute-on-Chronic Liver Failure in Chronic Hepatitis B Patients With Severe Acute Exacerbation.
Yu M; Li X; Lu Y; Jie Y; Li X; Shi X; Zhong S; Wu Y; Xu W; Liu Z; Chong Y
Front Med (Lausanne); 2021; 8():748915. PubMed ID: 34790679
[No Abstract] [Full Text] [Related]
4. Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation.
Lai CY; Yang SS; Lee SW; Tsai HJ; Lee TY
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768403
[TBL] [Abstract][Full Text] [Related]
5. IS EARLY AMBULATION SAFE IN VIRAL HEPATITIS?
Anand AC; Thakur SK; Singh WA; Dham SK
Med J Armed Forces India; 1994 Jan; 50(1):15-18. PubMed ID: 28769153
[TBL] [Abstract][Full Text] [Related]
6. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.
Tsai WL; Sun WC; Cheng JS
Int J Mol Sci; 2015 Nov; 16(12):28126-45. PubMed ID: 26703566
[TBL] [Abstract][Full Text] [Related]
7. Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.
Gao FY; Liu Y; Li XS; Ye XQ; Sun L; Geng MF; Wang R; Liu HM; Zhou XB; Gu LL; Liu YM; Wan G; Wang XB
World J Gastroenterol; 2015 Jul; 21(27):8373-81. PubMed ID: 26217089
[TBL] [Abstract][Full Text] [Related]
8. Update on entecavir in the management of severe forms of Hepatitis B.
Sacco R
Hepat Med; 2012; 4():39-47. PubMed ID: 24696620
[TBL] [Abstract][Full Text] [Related]
9. Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.
Tsai WL; Chiang PH; Chan HH; Lin HS; Lai KH; Cheng JS; Chen WC; Tsay FW; Wang HM; Tsai TJ; Yu HC; Hsu PI
Antimicrob Agents Chemother; 2014; 58(4):1918-21. PubMed ID: 24419351
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of Nucleos(t)ide analogues in patients with spontaneous acute exacerbation of chronic hepatitis B: a systematic review and meta-analysis.
Yu W; Zhao C; Shen C; Wang Y; Lu H; Fan J
PLoS One; 2013; 8(6):e65952. PubMed ID: 23776577
[TBL] [Abstract][Full Text] [Related]
11. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B.
Matsumoto K; Miyake Y; Miyatake H; Takahara M; Imada T; Yagi S; Toyokawa T; Nakatsu M; Ando M; Hirohata M
World J Gastroenterol; 2009 Apr; 15(13):1650-2. PubMed ID: 19340912
[TBL] [Abstract][Full Text] [Related]
12. Viral hepatitis in a Canadian street-involved population.
Moses S; Mestery K; Kaita KD; Minuk GY
Can J Public Health; 2002; 93(2):123-8. PubMed ID: 11963516
[TBL] [Abstract][Full Text] [Related]
13. A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B.
Sokal EM; Roberts EA; Mieli-Vergani G; McPhillips P; Johnson M; Barber J; Dallow N; Boxall E; Kelly D
Antimicrob Agents Chemother; 2000 Mar; 44(3):590-7. PubMed ID: 10681323
[TBL] [Abstract][Full Text] [Related]
14. Interferon in the management of chronic hepatitis B.
Perrillo RP
Dig Dis Sci; 1993 Apr; 38(4):577-93. PubMed ID: 8462360
[TBL] [Abstract][Full Text] [Related]
15. Chronic liver disease rarely follows acute hepatitis B in non-immunocompromised adults.
Roumeliotou A; Papaevangelou G
Infection; 1992; 20(4):221-3. PubMed ID: 1387866
[TBL] [Abstract][Full Text] [Related]
16. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection.
Seeff LB; Koff RS
Semin Liver Dis; 1986 Feb; 6(1):11-22. PubMed ID: 3012782
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
18. Serologic markers of hepatitis B virus infection.
Hoofnagle JH; Schafer DF
Semin Liver Dis; 1986 Feb; 6(1):1-10. PubMed ID: 3086979
[No Abstract] [Full Text] [Related]
19. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
